|
Dr. Carmen Ricos and colleagues update this database on within-subject and between-subject biologic variation. From this data, they also calculate desirable specifications for imprecision, inaccuracy, and total allowable error. We are honored to be able to host this database. This article lists the references that were used to develop the specifications.Updated for 2012.
Desirable Specifications for Total Error, Imprecision, and Bias, derived from Intra- and Inter-Individual Biologic Variation
This most recent and extensive listing of biologic goals has been provided by Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, Minchinela J, Perich C, Simon M. "Current databases on biologic variation: pros, cons and progress." Scand J Clin Lab Invest 1999;59:491-500. Updated analytes for 2001, 2004, 2006, 2008, 2010, 2012 included.
Annex II: Bibliographical references for each analyte studied
11-Desoxycortisol through Alanine aminotransferase Albumin through CA 549 antigen Calcium through Cysteine Dehydroepiandrosterone sulfate through Hydroxiproline Immunoglobulin A through Lysine Magnesium through Oxalate, output Paraoxon through Rheumatoid factor S Protein through Zinc
See The Actual References See The Actual Numbers! See The Guest Essay
|
Analyte |
Reference |
| S- |
11-Desoxycortisol |
136, 137 |
| S- |
17-Hydroxyprogesterone |
136, 137 |
| U- |
4-hydroxi-3-metoximandelate (VMA) |
90, 112 |
| S- |
5'Nucleotidase |
90, 112, 178 |
| U- |
5'-Hidroxiindolacetate, concentration |
133 |
| S- |
α1-Acid glycoprotein |
24,95,153 |
| S- |
α1-Antichymotrypsin |
24 |
| S- |
α1-Antitrypsin |
84,95,153 |
| P- |
α1-Globulins |
90, 92 |
| U- |
α1-Microglobulin, concentration, first morning |
105 |
| P- |
α2-Antiplasmin |
26 |
| S- |
α2-Globulins |
90, 92 |
| S- |
α2-Macroglobulin |
84,95,153 |
| U- |
α2-Microglobulin output, first morning |
105 |
| S- |
α-Amylase |
27,30,49,72,90,138,139 |
| S- |
α-Amylase (pancreatic) |
30,82 |
| U- |
α-Amylase concentration, random |
30 |
| P- |
α-Carotene |
198 |
| S- |
α-Carotene |
117 |
| S- |
α-Fetoprotein |
183, 219 |
| S- |
α-Tocopherol |
53, 117, 192 |
| S- |
Acid phosphatase (ACP) |
166,167 |
| S- |
Acid phosphatase prostatic, activity |
126 |
| S- |
Acid phosphatase tartrate resistent |
67, 124, 177 |
| P- |
Activated partial thromboplastine time (APTT) |
22,26,35 |
| S- |
Adenosine deaminase |
90 |
| P- |
Adiponectin |
199 |
| (B)Plat- |
Adrenaline |
20 |
| P- |
Adrenaline |
20 |
| S- |
Alanine aminopeptidase |
71 |
| S- |
Alanine aminotransferase |
27,46,71,90,138,139, 153,161,166,167 |
Back to top
|
Analyte |
Reference |
| S- |
Albumin |
24,27,37,45,46,47,49,53,62, 64,69,72,84,90,92,110,130, 138,139, 161,166,167,168 |
| U- |
Albumin, concentration, first morning |
78,80,86 |
| U- |
Albumin/Creatinine |
80 |
| S- |
Albumin, glycated |
31, 60, 129 |
| S- |
Aldosterone |
136,137 |
| U- |
Aldosterone, concentration |
133 |
| S- |
Alkaline phosphatase |
4,5,27,49,52,64,71,90,110,124, 130,138,153,161,165,166,167, 168,171,178 |
| S- |
Alkaline phosphatase, bone isoform |
67, 124, 171, 172 |
| S- |
Alkaline phosphatase, liver |
178 |
| S- |
Alkaline phosphatase, placental |
16 |
| U- |
Ammonia, output |
6 |
| S- |
Amyloid A |
189 |
| S- |
Androstendione |
136,137 |
| S- |
Angiotensin converting enzyme (Peptidil dipeptidase) |
41 |
| P- |
Antithrombin III |
22,26,106,159 |
| S- |
Apolipoprotein A1 |
13,21,44,49,93,104,107,120, 121,141,164 |
| S- |
Apolipoprotein B |
13,44,49,93,104,120,121,141,164 |
| P- |
Arginine |
214 |
| S- |
Arilestearase activity |
202 |
| P- |
Ascorbate |
198 |
| S- |
Ascorbate |
53, 192, 198 |
| P- |
Asparagine |
214 |
| S- |
Aspartate aminotransferase |
27,69,71,90,138,139,153,161,165, 166,167,168 |
| P- |
Aspartic acid |
214 |
| S- |
β2-Microglobulin |
24 |
| S- |
Basophile, count |
28,88,154 |
| S- |
β-Carotene |
53,98,117,198 |
| S- |
β-Cryptoxanthin |
117 |
| S- |
β-Globulins |
90,92 |
| S- |
Bilirubin total |
27,49,64,90,130,138,139,161,166, 200 |
| S- |
Bilirubin conjugated |
90,139 |
| Patient- |
Body mass |
106 |
| P- |
C Protein |
225 |
| S- |
C Reactive Protein |
24, 100, 197 |
| S- |
CA 125 antigen |
16, 109, 181, 201 |
| S- |
CA 15.3 antigen |
58,59,76,151, 211 |
| S- |
CA 19.9 antigen |
109,132,162 |
| S- |
CA 549 antigen |
16 |
Back to top
|
Analyte |
Reference |
| S- |
Calcium |
27,37,45,46,47,49, 52,62, 64,66,69,73,74,90,110,130, 138,139, 161,165,166,167,168 |
| S- |
Calcium, complexed |
110 |
| U- |
Calcium, concentration, 24h |
63,140,149,150 |
| U- |
Calcium, ionized |
110, 182 |
| U- |
Calcium, output, 24h |
63,66,140,149 |
| S- |
Calcium, protein bound |
110 |
| S- |
Calcium, ultrafiltrable |
110 |
| S- |
Carbohydrate deficient transferrin |
70 |
| (B)Gas- |
Carbon dioxide |
68 |
| S- |
Carbon dioxide |
68 |
| S- |
Carcinoembryonic antigen (CEA) |
16,58,59,76,109,151,181,185, 201, 211 |
| S- |
Carnitine, free |
193 |
| S- |
Carnitine, total |
193 |
| S- |
Ceruloplasmin (Ferroxidase) |
52, 95 |
| S- |
Chloride |
7,27,45,46,47,49,62,64,69, 71,74,90,130,138,161,166, 167,168 |
| S- |
Cholesterol |
8,13,21,23,27,32,39,44,49,50,53, 60,69,72,74,77,90,93,94,100, 104,107,108,114,120,121,138, 139,141,142,147,148,153,158, 161,163,164,165,166,167,168, 173,174,202 |
| S- |
Cholinesterase, activity |
11,90,112 |
| S- |
Cholinesterase, concentration |
11, 71 |
| S- |
Cholinesterase, immunoreactive |
11 |
| S- |
C3 complement |
95,153 |
| S- |
C4 complement |
95,153 |
| P- |
Chromogranin A |
208 |
| P- |
Citrulline |
214 |
| U- |
Colour |
225 |
| P- |
Copper |
97,52,61 |
| S- |
Copper |
52,98 |
| S- |
Cortisol |
136,137,153 |
| S- |
C Peptide |
136, 137, 213 |
| S- |
C- Propeptide type I procollagen |
67, 156, 172 |
| P- |
C-Reactive protein |
24,100 |
| S- |
Creatine kinase |
27,46,90,138,139,145,153,161,165 |
| S- |
Creatine kinase MB, % |
145 |
| S- |
Creatine kinase MB, activity |
27,90,138,145 |
| S- |
Creatine kinase MB, mass |
145 |
| S- |
Creatinine |
7,27,37,45,46,47,49,53,62,64, 65,72,90,110,138,139,143,161, 165,166,167,168,203, 221, 222, 223, 224 |
| Patient- |
Creatinine clearence |
65, 224 |
| Patient- |
Creatinine clearance MDRD |
224 |
| U- |
Creatinine, concentration |
63,65,78,140,149,150 |
| U- |
Creatinine, output |
6,10,12,14,63,65,78,140,149 |
| S- |
C-Terminal telopeptide type I collagen (s-CTx) |
67,156,184 |
| U- |
C-Terminal telopeptide type I collagen/creatinine, first and second morning urine |
55,67,89,171,184 |
| S- |
Cyfra 21.1 |
185,201 |
| P- |
Cystatin C |
223 |
| S- |
Cystastin C |
203, 221, 222, 224 |
| P- |
Cysteine |
25 |
| P- |
Cystine |
214 |
| P- |
δ-aminolevulinic acid |
195 |
Back to top
|
Analyte |
Reference |
| S- |
Dehydroepiandrosterone sulfate (DHEA) |
136,137,173 |
| U- |
Deoxipyridinoline/creatinine |
4,89,127 |
| P- |
Dipeptidyl-peptidase IV (ACE) |
99,103 |
| S- |
Dipeptidyl-peptidase IV (ACE) |
41 |
| P- |
Elastase |
2 |
| S- |
Endotelial growth factor |
190 |
| B- |
Eosinophils, count |
28,88,154 |
| B(Plat)- |
Epinephrine |
20 |
| PB- |
Epinephrine |
20 |
| B- |
Erythrocytes, count |
28,34,48,88,96,102 |
| S- |
Estradiol |
118,136,137,174 |
| U- |
Estradiol |
118 |
| S- |
Estradiol, free |
118 |
| U- |
Estradiol, free |
118 |
| P- |
Factor V coagulation |
26 |
| P- |
Factor VII coagulation |
22,159 |
| P- |
Factor VIII coagulation |
22,159 |
| P- |
Factor X coagulation |
26 |
| S- |
Ferritin |
1,9,27,52,131,200 |
| P- |
Fibrinogen |
22,26,102,144,159 |
| (B)Erythr- |
Folate |
173 |
| S- |
Folate |
173 |
| S- |
Follicle stimulating hormone (FSH) |
136,137,160,170 |
| S- |
Fructosamine |
31,49,79 |
| S- |
Galactosyl hydroxylisine |
118 |
| S- |
γ-Globulins |
90,92 |
| S- |
γ-glutamyltransferase |
27,70,71,90,138,139,153,165,178 |
| S- |
Globulins,total |
110 |
| P- |
Glucose |
226 |
| S- |
Glucose |
27,31,37,46,49,60,69, 90,138,139,165,168,186 |
| (B)Erythr- |
Glucose-6-phosphate-1-dehydrogenase |
169 |
| (B)Spot- |
Glucose-6-phosphate-1-dehydrogenase |
204 |
| P- |
Glutamic acid |
214 |
| P- |
Glutamine |
214 |
| S- |
Glutathione peroxidase |
29 |
| S- |
Glycated albumin |
31,60,129 |
| P- |
Glycine |
214 |
| P- |
Haptoglobin |
101 |
| S- |
Haptoglobin |
24,95,153 |
| B- |
Hematocrit |
1,9,28,34,48,52,88,96,102,154 |
| B- |
Hemoglobin |
1,9,28,34,48,52,71, 74,88,96,102,154 |
| B- |
Hemoglobin A1C |
60,129,173,176,180,186, 226, 229 |
| S- |
HDL cholesterol |
8,13,21,23,32,39,50,53,60,72, 74,77,93,94,104,107,108,114, 120,21,141,147,148,164 |
| S- |
HDL 1 cholesterol |
44 |
| S- |
HDL 2 cholesterol |
13,21,44,60,120,121 |
| S- |
HDL 3 cholesterol |
13,21,44,60,120,121 |
| P- |
Histidine |
214 |
| P- |
Homocysteine |
54, 146, 177 |
| S- |
Hydroxibutyrate dehydrogenase |
27 |
| P- |
Hydroxiproline |
214 |
| S- |
Hydroxiproline/creatinine |
5, 110, 171 |
| U- |
Hydroxiproline/minute, night urine |
5 |
Back to top
|
Analyte |
Reference |
| S- |
Immunoglobulin A |
42,43,49,95,153,173,174 |
| S- |
Immunoglobulin G |
42,43,49,95,153,207 |
| S- |
Immunoglobulin M |
42,43,49,95,153 |
| S- |
Immunoglobulins κ chain |
42,43,49 |
| S- |
Immunoglobulins λ chain |
42,43,49 |
| S- |
Insulin |
37,60,136,137 |
| S- |
Insulin-like growth factor-1 (IGF-1) |
209, 218 |
| S- |
Insulin-like growth factor binding protein 3 (IGFBP-3) |
218 |
| S- |
Interleukin 1-β |
175 |
| S- |
Interleukin 8 |
175 |
| S- |
Intercellular adhesion molecule-1 (ICAM-1) |
200 |
| (B)Leuc- |
Interferon receptor |
56 |
| (B)Leuc- |
Iron |
1,9,27,81,90,96,131,152, 155,166,167 |
| P- |
Isoleucine |
214 |
| S- |
Lactate dehydrogenase (LDH) |
27,69,90,111,138,139,153, 161,165,167,168 |
| S- |
Lactate dehydrogenase 1 isoform |
90,111 |
| S- |
Lactate dehydrogenase 2 isoform |
111 |
| S- |
Lactate dehydrogenase 3 isoform |
111 |
| S- |
Lactate dehydrogenase 4 isoform |
111 |
| S- |
Lactate dehydrogenase 5 isoform |
111 |
| B- |
Lactate |
125 |
| P- |
Lactoferrin |
2 |
| P- |
Leucine |
214 |
| P- |
Leukocytes, count |
28,34,36,48,88,96,154 |
| S- |
LDL Cholesterol |
8,13,21,39,50,93,94,104,107, 108,114,120,121,141,148,164 |
| S- |
LDL Cholesterol (direct) |
148 |
| P- |
LDL Cholesterol oxidized |
200 |
| S- |
LDL receptor mRNA |
128 |
| S- |
Lipase |
49,82,90 |
| S- |
Lipoprotein (a) |
104,115,121 |
| P- |
Lutein |
198 |
| S- |
Lutein |
117 |
| S- |
Luteinizing hormone (LH) |
136,137,160,170 |
| S- |
Lycopenene |
117, 198 |
| B- |
Lymphocytes, count |
28,36,48,88,154 |
| B- |
Lymphocytes, CD4 |
191 |
| P- |
Lysine |
214 |
Back to top
|
Analyte |
Reference |
| (B)Erythr- |
Magnesium |
38, 51 |
| (B)Leuc- |
Magnesium |
38, 51 |
| S- |
Magnesium |
33,37,38,52,61,69,139,165,168 |
| U- |
Magnesium, concentration, 24h |
33,116 |
| U- |
Magnesium, ionized |
182 |
| U- |
Magnesium, output, 24h |
33,116 |
| S- |
MC antigen (MCA) |
18,76 |
| (B)Erythr- |
Mean corpuscular hemoglobin (MCH) |
34,88,102 |
| (B)Erythr- |
Mean corpuscular hemoglobin concentration |
34,48,96,102 |
| (B)Erythr- |
Mean corpuscular volume (MCV) |
34,48,70,88,96,102 |
| (B)Plat- |
Mean platelet volume (MPV) |
28,88,102 |
| P- |
Methionine |
214 |
| B- |
Monocytes, count |
28, 88, 154 |
| S- |
Myoglobin |
122,145 |
| S- |
Myeloperoxidase |
210 |
| U- |
N-Acetyl Glucosaminidase, concentration |
83,157 |
| U- |
N-Acetyl Glucosaminidase/Creatinine |
157 |
| U- |
N- Telopeptide type I collagen /creatinine |
89,135,170, 177 |
| U- |
N- Telopeptide type I collagen /creatinine, first urine |
89,135,171,172 |
| B- |
Neutrophils, count |
28,36,48,88,154 |
| U- |
Nitrogen, output |
6 |
| S- |
Non-inhibited arilestearase activity |
202 |
| B(Plat)- |
Norepinephrine |
20 |
| P- |
Norepinephrine |
20 |
| S- |
N-terminal (NT)-proBNP |
205,206 |
| P- |
Ornithine |
214 |
| P- |
Osmolality |
225 |
| Saliva- |
Osmolality |
225 |
| S- |
Osmolality |
49,85 |
| S- |
Osteocalcin |
4,5,67,124,172 |
| U- |
Oxalate, concentration, 24h |
3 |
| U- |
Oxalate, output, 24h |
3 |
Back to top
|
Analyte |
Reference |
| S- |
Paraoxonase |
202 |
| S- |
Paraoxonase 1 substrate inhibition (PON 4SI) |
202 |
| S- |
Paraoxonase activity (salt stimulated) |
202 |
| S- |
Parathyroid hormone (PTH) |
209 |
| S- |
Peptidil dipeptidase A (ECA) |
41 |
| B- |
pH |
68 |
| B(Gas)- |
pCO2 |
68 |
| S- |
Phenylacetate |
202 |
| P- |
Phenylalanine |
214 |
| S- |
Phosphate |
27,37,49,53,64,69,90, 110,130,138,139,161, 165,166,167,168 |
| U- |
Phosphate, concentration, 24h |
63,140,149,150 |
| U- |
Phosphate, output, 24h |
63,66,140,149 |
| Patient- |
Phosphate tubular reabsorption |
66 |
| S- |
Phospholipids |
119 |
| P- |
Plasminogen |
26 |
| B- |
Platelet, count |
28,34,48,88,102,154 |
| B- |
Platelet distribution wide |
28,88 |
| B- |
Plateletcrit |
28,88 |
| U- |
Porphobilinogen |
195 |
| U- |
Porphyrins, total |
195 |
| (B)Leuc- |
Potassium |
51 |
| S- |
Potassium |
7,27,37,45,46,47,49, 64,69,71,74,90,130, 138,139,161,166,167,168 |
| U- |
Potassium, concentration |
63,140,149,150 |
| U- |
Potassium, output |
6,63,140,149 |
| S- |
Prealbumin |
24 |
| S- |
Procollagen type 1 C-terminal |
67, 156, 172 |
| S- |
Procollagen type 1 N-terminal |
67, 172 |
| S- |
Procollagen type III N propeptide (PIIINP) |
218 |
| S- |
Prolactin |
136,137,173,174 |
| P- |
Proline |
214 |
| P- |
Prolyl endopeptidase |
99,103 |
| S- |
Properdin factor B |
195 |
| S- |
Protein |
27,37,49,53,64,69, 72,90,95,130,138,139,161 ,165,166,167,168 |
| U- |
Protein, concentration, 24h |
140,149,150 |
| S- |
Protein, glycated |
31 |
| U- |
Protein, output, 24h |
140,149 |
| S- |
Prostatic acid phosphatase, activity |
126 |
| S- |
Prostatic specific antigen (PSA) |
16,126,181 |
| P- |
Prothrombin time |
26,35 |
| Patient- |
Phosphate tubular reabsorption |
66 |
| U- |
Pyridinoline/creatinine, morning spot |
4,5 |
| U- |
Pyridinoline/minute |
5 |
| B- |
Pyruvate |
125 |
| B- |
Red cell distribution wide |
28,34,88,102 |
| S- |
Reticulocyte, count |
179 |
| S- |
Reticulocyte highly fluourescent, count |
179 |
| S- |
Reticulocyte medium fluourescent, count |
179 |
| S- |
Reticulocyte low fluourescent, count |
179 |
| P- |
Retinol |
198 |
| S- |
Retinol |
53,117 |
| S- |
Rheumatoid factor |
87 |
| (B)Eryth- |
Riboflavin |
177 |
Back to top
|
Analyte |
Reference |
| P- |
S Protein |
106 |
| S- |
SCC antigen |
109 |
| P- |
Selenium |
97 |
| B- |
Selenium |
97 |
| Semen- |
Spermatozoa, concentration |
196 |
| Semen- |
Spermatozoa, motility |
196 |
| Semen- |
Spermatozoa, progressive motility |
196 |
| Semen- |
Spermatozoa, progressive rapid motility |
196 |
| Semen- |
Spermatozoa, morphology |
196 |
| Semen- |
Spermatozoa, vitality |
196 |
| S- |
Sex hormone binding globulin (SHBG) |
160 |
| (B)Erythr- |
Sodium |
51 |
| (B)Leuc- |
Sodium |
51 |
| S- |
Sodium |
7,27,37,45,46,47,49,62, 64,69,71,74,90,130,138, 139,161,166,167, 168 |
| S- |
Sodium bicarbonate |
45, 46, 68, 69, 110, 161, 168 |
| Sweat- |
Sodium chloride |
187 |
| U- |
Sodium, concentration, 24h |
63,140,149,150 |
| U- |
Sodium, output, 24h |
6,63,140,149 |
| P- |
Soluble CD163 |
188 |
| U- |
Specific gravity |
225 |
| (B)Erythr- |
Superoxide dismutase |
29 |
| S- |
Superoxide dismutase |
52 |
| P- |
Taurine |
214 |
| Saliva- |
Testosterone |
160 |
| S- |
Testosterone |
118,136,137,160,170 |
| U- |
Testosterone |
118 |
| S- |
Testosterone, free |
118, 173, 174 |
| U- |
Testosterone, free |
118 |
| S- |
Tissue polypeptide antigen (TPA) |
109,151 |
| S- |
Tissue polypeptide specific antigen (TPS) |
109 |
| P- |
Threonine |
214 |
| S- |
Thyroglobulin |
40,207 |
| S- |
Thyroglobulin antibody |
207 |
| S- |
Thyroid peroxidase antibody |
207 |
| S- |
Thyroid stimulating hormone (TSH) |
15,17,19,40,90,134,136,137,209 |
| S- |
Thyrotropin receptor antibody |
207 |
| S- |
Thyroxine binding globulin (TBG) |
40,136 |
| S- |
Thyroxine (T4) |
15,17,19,40,75,91,134, 136,137,165 |
| S- |
Thyroxine/TBG |
40 |
| S- |
Thyroxine, free (FT4) |
15, 17, 19, 134, 209 |
| U- |
Total catecholamine concentration, 24h |
133 |
| S- |
Transferrin |
27,52,70,95,153 |
| S- |
Triglyceride |
8,13,21,27,32,39,49,50,53, 60,72,74,90,93,94,104,107, 108,120, 121,138,139,141, 148,153,161,163,164,165 |
| S- |
Triiodothyronine (T3) |
15,17,19,27,40,75,91, 134,136,137 |
| S- |
Triiodothyronine/ TBG |
40 |
| S- |
Triiodothyronine, free (FT3) |
15, 17, 19, 209 |
| S- |
Triiodothyronin, uptake |
40 |
| S- |
Triiodothyronine captation |
40 |
| S- |
Troponin I |
212, 228 |
| S- |
Troponin T |
217, 227 |
| P- |
Tryptophan |
214 |
| S- |
Tumor Necrosis factor-α
|
175 |
| P- |
Tyrosine |
214 |
| S- |
Urate |
7,27,37,53,69,72,90,138, 139,161,165,166,167,168,200 |
| U- |
Urate, concentration, 24h |
140,149,150 |
| U- |
Urate, output, 24h |
140,149 |
| S- |
Urea |
7,27,37,45,46,47,49,64, 69,72,90,130,138,139,161, 165,166,167,168 |
| U- |
Urea, concentration |
63,140,149,150 |
| U- |
Urea, output |
6,63,140,149 |
| P- |
Valine |
214 |
| S- |
Vanilmandelic Acid, concentration |
133 |
| S- |
Vascular cell adhesion molecule-1 (VACM-1) |
200 |
| B- |
Vascular endotelial growth factor |
190 |
| P- |
Vascular endotelial growth factor |
190 |
| S- |
Vascular endotelial growth factor |
190 |
| S- |
VLDL Cholesterol |
39,108 |
| P- |
Vitamin B1 |
198 |
| (B)Erythr- |
Vitamin B2 (Riboflavin) |
198 |
| (B)Erythr- |
Vitamin B2 status (Riboflavin) |
177 |
| (B)Erythr- |
Vitamin B6 |
198 |
| (B)Erythr- |
Vitamin B6 status (AST activation) |
177 |
| (B)Erythr- |
Vitamin B12 |
177 |
| (B)Erythr- |
Vitamin E (a-Tocopherol) |
198 |
| (B)Erythr- |
Vitamin K (Phylloquinone) |
198 |
| P- |
Von Willebrand factor |
22,159, 200 |
| P- |
Von Willebrand factor antigen |
200 |
| S- |
Water |
49,85 |
| S- |
Zeaxanthine |
117 |
| S- |
Zinc |
52,57,61 |
| P- |
Zinc |
97 |
Back to top
|